Company: ANY
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001591956-25-000014
Chunk: 20

Company: Sphere 3D Corp.
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 1
Chunk 20
---
 of the AGP Agreement, the Company may offer and sell from time to time through or to the Sales Agent, as agent or principal, the Company's common shares having an aggregate offering price of up to $8.0 million (the “Placement Shares”). The AGP Agreement can be terminated by either party by giving two days written notice.Neither the Company nor the Sales Agent are obligated to sell any Placement Shares pursuant to the AGP Agreement. Subject to the terms and conditions of the AGP Agreement, the Sales Agent will use commercially 

16

reasonable efforts, consistent with its normal trading and sales practices and applicable state and federal law, rules and regulations and the rules of Nasdaq, to sell the Placement Shares from time to time based upon the Company’s instructions, including any price, time or size limits or other customary parameters or conditions the Company may impose. Sales of the Placement Shares, if any, will be made on Nasdaq at market prices by any method permitted by law deemed to be an “at the market offering” as defined in Rule 415 of the Securities Act of 1933, as amended. For the three and nine months ended September 30, 2025, under the AGP Agreement the Company issued 917,431 and 1,127,879 common shares, respectively, for $0.6 million and $0.7 million of net proceeds, respectively. Pre-Funded WarrantsOn November 19, 2024, Company issued pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 1,875,353 of the Company's common shares. The Pre-Funded Warrants had a purchase price of $1.4199 per share, an exercise price of $0.0001 per share, and were exercisable immediately. For the three and nine months ended September 30, 2025, the Pre-Funded Warrants to purchase nil and 1,594,000 common shares were exercised. There are no Pre-Funded Warrants outstanding at September 30, 2025.Unlimited authorized shares of common shares at no par value are available to the Company. At September 30, 2025, the Company had the following outstanding warrants to purchase common shares:Date issuedContractual life (years)Exercise priceNumber outstandingExpirationSeptember 20215$66.501,429,422 September 8, 2026February 20225$28.0014,286 February 7, 2027February